Connecticut’s 2026 legislative session produced the most significant changes to the state’s cannabis laws since legalization. Through Connecticut House Bills (“HB”) 5350 and 5222 (together, the “Legislation”), the General Assembly expanded opportunities for cannabis, hemp, and infused beverage businesses while also imposing sweeping new restrictions on social equity ownership, operational control, and business relationships.

The Legislation affects nearly every segment of Connecticut’s regulated cannabis industry, from social equity cannabis license holders to infused beverage manufacturers, hemp businesses, to investors, and backers. While the new laws create opportunities for businesses in the cannabis and infused beverage industries, they also introduce complex compliance requirements that may require businesses to revisit ownership structures, financing arrangements, operating agreements, and product classifications.

Businesses operating in Connecticut’s cannabis, hemp, food and beverage, and retail sectors should review these changes carefully before the new requirements take effect:

Key Business Impacts

New Social Equity Rules (from November 1, 2026)

HB 5222 significantly increases oversight of equity joint ventures by restricting agreements that transfer operational control away from social equity owners, creating new ownership review procedures, and expanding Social Equity Council enforcement authority. In particular, there are: (a) new restrictions on ownership, operational control, and management/operational agreements involving social equity businesses, and (b) new annual certification requirements regarding social equity businesses’ ownership, control, and financings.

Notably, HB 5222 now imposes more significant regulatory and civil penalties for non-compliance, with possible enforcement actions resulting in fines of up to $10 million or actions against licenses.

New Compliance Requirements (effective as of October 1, 2026)

Licensed cannabis businesses should pay particular attention to several new compliance obligations, including:

  • New limitations on financing and trade credit arrangements between cannabis establishments.
  • Updated packaging and labeling requirements, including expanded warning label requirements for certain high-potency products.
  • Simplified transportation and delivery rules under specified security conditions.

Growth of the Infused Beverage Market (effective as of October 1, 2026)

The legislation increases allowable THC limits for infused beverages, expands retail and on-premises sales opportunities for manufacturers, and creates additional pathways for hemp-derived ingredients to be used in regulated products.

Updated Hemp and Cannabis Definitions (from December 1, 2026)

The law clarifies how hemp-derived products, manufactured cannabinoids, and minor cannabinoids are regulated. Businesses should not assume that hemp-derived products fall outside Connecticut’s cannabis laws, as several products are now expressly regulated.

Expanded Medical Cannabis Definitions Access (effective as of October 1, 2026)

Connecticut’s medical cannabis program will now serve qualifying out-of-state patients and caregivers, creating new opportunities for licensed dispensaries and hybrid retailers.

New Tax Structure (effective as of October 1, 2026)

Adult-use cannabis will transition from a potency-based excise tax to a flat 10.75% retail cannabis tax, simplifying pricing and tax administration for retailers.

Looking Ahead

Many of the Legislation’s most significant provisions do not become effective until later in 2026. Additional guidance from the Department of Consumer Protection and the Social Equity Council is expected and will likely shape how these changes are implemented in practice.

Because many of these changes affect ownership structures, financing arrangements, and management agreements, cannabis businesses should understand the new requirements before entering into future transactions.

To discuss how these changes may affect your business, please contact our Cannabis & Hemp industry team:

Ben Pomerantz
Partner
203.252.2645
[email protected]

Kevin Palumberi
Partner
203.252.2692
[email protected]

Carmody’s full-service Cannabis & Hemp team has considerable experience guiding and helping clients become established in the rapidly expanding cannabis and hemp industries. 

Authors: Ben Pomerantz and Kevin Palumberi are partners in Carmody’s Cannabis practice area. Ellie Stepanskiy is a second-year law student at University of Connecticut School of Law and is currently a Summer Associate at Carmody.

This information is for educational purposes only to provide general information and a general understanding of the law. It does not constitute legal advice and does not establish any attorney-client relationship.